Hetero Labs and Gedeon Richter Forge Strategic Partnership to Develop Generic Semaglutide
In a significant move for the global pharmaceutical market, Indian drugmaker Hetero Labs and Hungarian pharmaceutical giant Gedeon Richter announced a strategic collaboration this week to develop and commercialize a generic version of the blockbuster drug Semaglutide. The partnership aims to increase access to the high-demand GLP-1 receptor agonist, which is currently used to treat…